Willow tirzepatide review
Advertised at $399 and billed at $399 — no gap. Position 15 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
One number, $399 a month, no membership and no tiers. The simplest listing on the board and among the dearest.
There is real value in a price that does not need arithmetic. There is less value in it being roughly double the cheapest full-dose compounded tirzepatide we track.
The numbers
| Willow · tirzepatide | |
|---|---|
| Advertised | $399/mo |
| Membership | None |
| Billed | $399/mo |
| Advertised-to-billed gap | None |
| Per year | $4,788 |
| Board position | 15 of 18, cheapest first |
One published rate, no membership layer.
Where the gap is
No fee gap to report. What is missing is information: which pharmacy fills it, whether that is a 503A or 503B facility, and how dose changes are reviewed are all unpublished.
Against the board
About $4,788 a year. Coreage Rx runs $2,388 month-to-month for the same category of medication.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Compounded GLP-1 provider with a single published monthly rate.
Verified facts
- Compounded tirzepatide listed at $399/month.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- A single price with no membership arithmetic.
Against it
- At $399/month it is priced well above the flat-rate leaders.
- Thinner published detail about clinical support than larger competitors.
Read this bit. There is little published detail on how dose changes are handled. Ask before committing.
Score
2.9 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 2.4 / 5 |
| Price honesty | 20% | 3 / 5 |
| Clinical support | 20% | 3.1 / 5 |
| Pharmacy sourcing | 15% | 3.1 / 5 |
| Cancelling | 15% | 3 / 5 |
Verdict
Clear pricing, high pricing, thin disclosure. Ask about pharmacy sourcing and dose management before committing.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.